Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Lichen planopilaris causes permanent hair loss and scarring due to damage to hair follicles and can be mistaken for other hair loss conditions.

Women in Australia report different signs of facial aging compared to women in the US, UK, and Canada; men with Lichen planopilaris often have hormonal abnormalities and thyroid disease.

A woman's hair loss was misdiagnosed as alopecia areata but was actually lichen planopilaris, needing immediate and ongoing treatment.

The study found that Frontal Fibrosing Alopecia in North-East India mainly affects middle-aged women and is often associated with lichen planus pigmentosus.

Dermoscopy helps diagnose and monitor treatment for hair loss from scarring conditions like discoid lupus and lichen planopilaris.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

The study found no significant link between the symptoms, tissue analysis, and immunofluorescence results in scarring hair loss conditions.

Frontal fibrosing alopecia may affect nails and could be a type of lichen planus, treatable with certain medications.

Lichen planopilaris can be triggered by prolonged scalp traction and can be treated with corticosteroids.

LC-OCT is an effective new method for diagnosing classic lichen planopilaris.

Thalidomide significantly improved hair regrowth in a woman with lichen planopilaris.

The conclusion is that proper recognition and treatment of skin conditions are crucial for the elderly due to changes in skin, nails, and hair with age, and the impact of these conditions on health and mobility.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Many hair diseases, including those caused by medications and psychological issues, can lead to hair loss and require proper treatment and specialist care.

Pseudopelade of Brocq is hard to diagnose and treat, with limited effective options.

The document reviews various hair and nail disorders, their causes, and treatments, emphasizing the need for proper diagnosis and the link between nail changes and systemic diseases.

The woman has a scalp condition causing hair loss.

Dermoscopy is a useful tool for identifying features of skin conditions, but more research is needed to define its role in dermatology.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.

Avoiding allergens can improve skin and hair conditions in adults with allergic reactions.

The document suggests a possible link between mast cells and scarring alopecia, recommending more research for potential treatments.

Reflectance confocal microscopy helped diagnose and manage a woman's hair loss without needing a biopsy.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

Tacrolimus solution is effective and well-tolerated for treating inflammatory scalp conditions.